The overexpression of proapoptotic factors, eg Mcl-1, bcl-2 or bcl-xL, has been implicated in cancer development, tumour progression and therapy resistance of B-cell lymphoproliferative diseases (Bannerji et al, 2003). The gene discussed is BCL2L1; the disease is neoplasm.